ONL Therapeutics

0 followers


ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to protecting and improving the vision of patients with a range of retinal diseases and conditions.

Industries

Headquarters

Stage

Employees

Links

Org chart

David Esposito
President & CEO

David Esposito

Collapse
David Zacks
Co-Founder & Chief Science Officer
Connie Chang
Chief Operating Officer
Jana Van De Goor
VP, Development
Amanda Maciel
Manager of Accounting and Financial Reporting.
Sushanta Mallick, PhD, MBA
Chief Development Officer
Wen Jing Chen
Chief Operating Officer
Xiao Ting Sun
Chief Operating Officer